雌激素在围手术期辅助治疗宫腔粘连的研究进展被引量：25

Advances of Perioperative Estrogen Therapy in Patients with Intrauterine Adhesions

在线阅读下载PDF

导出

摘要随着宫腔操作的增加及宫腔镜手术的普及,宫腔粘连发病率逐年增加。目前,宫腔粘连分离术是治疗宫腔粘连患者的有效手段,雌激素作为围手术期的辅助治疗方法被广泛用于临床,但是雌激素治疗仍以经验性治疗为主。本文主要通过复习近期相关文献,了解宫腔粘连时子宫内膜的变化,深入探究雌激素治疗宫腔粘连的作用机制、有效性,并总结雌激素在围手术期治疗宫腔粘连的用药剂量、时间、模式等治疗策略,为围手术期宫腔粘连患者的雌激素治疗方案提供依据。 Recently, with the popularity of intrauterine operation, the incidence of intrauterine adhesions（IUA） is increasing gradually. Hysteroscopic adhesiolysis has become an effective treatment of IUA. Estrogen use as an perioperative adjuvant therapy has been extensively applied to clinical practice,however the treatment remains empirically based. The purpose of this article was to review the literature to understand changes of endometrium with intrauterine adhesions and to analyze the mechanism and efficacy of estrogen therapy. Furthermore, this article summarized the dose,duration and other treatment strategies of estrogen,which provide evidence to use estrogen as perioperative adjuvant therapy in IUA.

作者陈熹婷陈勍刘畅浩黄妙玲管媚媚

机构地区中山大学孙逸仙纪念医院妇瘤科

出处《国际妇产科学杂志》 CAS 2016年第3期254-257,共4页 Journal of International Obstetrics and Gynecology

关键词子宫疾病黏连雌激素类宫腔镜宫腔镜检查子宫内膜 Uterine diseases Adhesions Estrogens Hysteroscopes Hysteroscopy Endometrium

分类号 R713.4 [医药卫生—妇产科学]

作者简介通信作者：陈勍,E-mail：sumsqing@139.com

引文网络
相关文献

参考文献24

1Conforti A , Alviggi C , Mollo A , e t al. The management of Ashermansyndrome: a review of literature [J]. Reprod Biol Endocrinol,2013,11:118.
2Malhotra N ,Bahadur A ,Kalaivani M,et al. Changes in endometrial receptivity in women with Asherman,s syndrome undergoinghysteroscopic adhesiolysis [J]. Arch Gynecol Obstet,2012,286(2):525-530.
3Chen Y,Chang Y,Yao S. Role of angiogenesis in endometrial repairof patients with severe intrauterine adhesion [J]. Int J Clin ExpPathol, 2013,6(7): 1343-1350.
4Mohamed Amer MI, Omar OH, El Sherbiny Hamed M,et al.Subendometrial blood flow changes by 3-dimensional power Dopplerultrasound after hysteroscopic lysis of severe intrauterine adhesions:preliminary study [J]. J Minim Invasive Gynecol,2015,22(3) :495-500.
5Heryanto B , Rogers PA. Regulation of endometrial endothelial cellproliferation by oestrogen and progesterone in the ovariectomizedmouse [J]. Reproduction, 2002,123(1)107-113.
6Okada H,Tsutsumi A,Imai M,et al. Estrogen and selective estrogenreceptor modulators regulate vascular endothelial growth factor andsoluble vascular endothelial growth factor receptor 1 in humanendometrial stromal cells [J]. Fertil Steril ,2010,93( 8) : 2680-2686.
7Sugino N, Kashida S , Karube-Harada A , et al. Expression of vascularendothelial growth factor (VEGF) and its receptors in humanendometrium throughout the menstrual cycle and in early pregnancy[J]. Reproduction,2002,123(3) : 379-387.
8Evans-Hoeker EA, Young SL. Endometrial receptivity andintrauterine adhesive disease [J]. Semin Reprod Med,2014,32(5):392-401.
9Fernandez H ,Peyrelevade S ,Legendre G,et al. Total adhesionstreated by hysteroscopy: must we stop at two procedures- [J]. FertilSteril,2012,98(4):980-985.
10Johary J, Xue M, Zhu X, et al. Efficacy of estrogen therapy in patientswith intrauterine adhesions : systematic review [J]. J Minim InvasiveGynecol, 2014,2 ( ( 1) : 44-54.